P2.11A.06 Tumor-Informed ctDNA Status Guiding 1st-line Immuno-Chemotherapy in Advanced NSCLC: CHOICE-01 Retrospective Analysis

DOI: 10.1016/j.jtho.2024.09.456 Publication Date: 2024-10-16T02:47:11Z